NCT04165876

Brief Summary

The purpose of this study is to investigate the efficacy of high definition tDCS on different cortical targets in modulating the nociceptive system in the healthy subjects.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
81

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 18, 2018

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

September 11, 2019

Completed
2 months until next milestone

First Posted

Study publicly available on registry

November 18, 2019

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 18, 2020

Completed
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 18, 2020

Completed
Last Updated

June 11, 2020

Status Verified

June 1, 2020

Enrollment Period

1.2 years

First QC Date

September 11, 2019

Last Update Submit

June 11, 2020

Conditions

Keywords

tDCSHD-tDCSSomatosensory functionQSTquantitative sensory testingNon-invasive brain stimulationNIBSTranscranial Direct Current Stimulation

Outcome Measures

Primary Outcomes (1)

  • Change in pressure pain threshold

    A hand-held pressure algometer (Somedic, Hörby, Sweden) with a 1-cm2 probe will be used to record the pressure pain threshold. The pressure is increased gradually at a rate of 30 kPa/s. The measurement is repeated three times on on flexor carpi radialis.

    Six assessments over three days: Baseline is assessed before any intervention at day one, and then the pain thresholds are assessed before and after each intervention on the subsequent two days.

Secondary Outcomes (7)

  • Change in tactile detection threshold

    Six assessments over three days: Baseline is assessed before any intervention at day one, and then the sensory thresholds are assessed before and after each intervention on the subsequent two days.

  • Change in mechanical pain threshold

    Six assessments over three days: Baseline is assessed before any intervention at day one, and then the sensory thresholds are assessed before and after each intervention on the subsequent two days.

  • Change in Thermal Sensory Detection

    Six assessments over three days: Baseline is assessed before any intervention at day one, and then the sensory thresholds are assessed before and after each intervention on the subsequent two days.

  • Change in Thermal Pain Detection

    Six assessments over three days: Baseline is assessed before any intervention at day one, and then the sensory thresholds are assessed before and after each intervention on the subsequent two days.

  • Change in conditioned pain modulation (CPM)

    Six assessments over three days: Baseline is assessed before any intervention at day one, and then the sensory thresholds are assessed before and after each intervention on the subsequent two days.

  • +2 more secondary outcomes

Study Arms (4)

Primary motor cortex

ACTIVE COMPARATOR
Device: Primary Motor Cortex Stimulation

Dorsolateral prefrontal cortex

ACTIVE COMPARATOR
Device: Dorsolateral Prefrontal Cortex Stimulation

Multi-modal stimulation (DLPFC+M1)

ACTIVE COMPARATOR
Device: Multimodal Stimulation (DLPFC+M1)

Sham-stimulation

SHAM COMPARATOR
Device: Sham stimulation

Interventions

Using the Starstim 32, HD-tDCS equipment we provide 20 minutes of 2 mA anodal stimulation of primary motor cortex (M1) using a ring-cathode configuration

Primary motor cortex

Using the Starstim 32, HD-tDCS equipment we provide 20 minutes of 2 mA anodal stimulation of dorsolateral prefrontal cortex (DLPFC) using a ring-cathode configuration

Dorsolateral prefrontal cortex

Using the Starstim 32, HD-tDCS equipment we provide 20 minutes of 2 mA anodal multimodal stimulation of dorsolateral prefrontal cortex (DLPFC) and primary motor cortex simultaneously using ring-cathode configurations around the two anodes.

Multi-modal stimulation (DLPFC+M1)

Using the Starstim 32, HD-tDCS equipment we provide sham stimulation with 30 seconds of ramping up to 2 mA intensity, then turning off for 19 minutes and then ramping down from 2 mA intensity to 0 in the last 30 seconds.

Sham-stimulation

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy men and women.
  • Able to speak, read and understand English or Danish.

You may not qualify if:

  • Pregnancy
  • Drug addiction defined as the use of cannabis, opioids or other drugs
  • Current use of opioids, antipsychotics, benzodiazepines
  • Previous or current neurological, musculoskeletal, rheumatic, malignant, inflammatory or mental illnesses
  • Current or prior chronic pain conditions
  • Lack of ability to cooperate

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Center for Neuroplasticity and Pain

Aalborg, North Denmark, 9000, Denmark

Location

Related Publications (1)

  • Kold S, Graven-Nielsen T. Effect of anodal high-definition transcranial direct current stimulation on the pain sensitivity in a healthy population: a double-blind, sham-controlled study. Pain. 2021 Jun 1;162(6):1659-1668. doi: 10.1097/j.pain.0000000000002187.

MeSH Terms

Conditions

Acute Pain

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Thomas Graven-Nielsen, Prof.

    Aalborg University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The stimulation protocol is blinded and randomized using the software's "double-blinding" function. The subjects are randomly assigned to one of four groups receiving the corresponding stimulation protocol. One of which is a sham-stimulation (placebo), that imitates the experience of real stimulation.
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: Longitudinal, sham-controlled, parallel groups design.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD-fellow

Study Record Dates

First Submitted

September 11, 2019

First Posted

November 18, 2019

Study Start

December 18, 2018

Primary Completion

February 18, 2020

Study Completion

March 18, 2020

Last Updated

June 11, 2020

Record last verified: 2020-06

Data Sharing

IPD Sharing
Will not share

Locations